Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhiguo Luo

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Radiation Research|October 30, 2025
Proline Intake Dampens Radiosensitivity in Prostate Cancer Cells by Targeting PRODH/MAPK PathwayLei Chang, Xinzhou Deng, Shan Jiang, et al.
Cancer Biology & Therapy|April 24, 2014
A phase II randomized trial evaluating gefitinib intercalated with pemetrexed/platinum chemotherapy or pemetrexed/platinum chemotherapy alone in unselected patients with advanced non-squamous non-small cell lung cancerHui Yu, Jian Zhang, Xianghua Wu, et al.
Investigational New Drugs|November 3, 2021
Rh-endostatin combined with chemotherapy in patients with advanced or recurrent mucosal melanoma: retrospective analysis of real-world dataXiaowei Zhang, Feng Jin, Shiyu Jiang, et al.
Frontiers in Oncology|December 16, 2021
GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung AdenocarcinomaJiahui Han, Xinzhou Deng, Renhuang Sun, et al.
Cancer Research and Treatment|March 14, 2023
Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center StudyXin Liu, Chengcheng Gong, Jieyun Zhang, et al.
Cell Communication and Signaling : CCS|February 7, 2024
1-Pyrroline-5-carboxylate inhibit T cell glycolysis in prostate cancer microenvironment by SHP1/PKM2/LDHB axisLei Chang, Guohao Li, Shan Jiang, et al.
Cell Death & Disease|July 3, 2020
Chondroitin polymerizing factor (CHPF) promotes development of malignant melanoma through regulation of CDK1Wei Sun, Fang Zhao, Yu Xu, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|August 24, 2025
A highly sensitive ESIPT fluorescent probe for visualization of HK2-mediated lung cancer progression via imaging nitroreductaseMiao Chen, Kelong Wang, Han Zhang, et al.
Clinical and Translational Medicine|April 16, 2025
Fruquintinib as first-line or second-line treatment in unresectable or metastatic soft-tissue sarcoma: A prospective, single-arm phase II studyXiaowei Zhang, Ting Zhao, Biqiang Zheng, et al.
Nature Communications|May 8, 2026
Anti-PD-1 plus nab-paclitaxel and bevacizumab for second-line treatment of cancer of unknown primary (Fudan CUP-002): a phase II trialXiaowei Zhang, Ting Zhao, Midie Xu, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Radiation Research|October 30, 2025
Proline Intake Dampens Radiosensitivity in Prostate Cancer Cells by Targeting PRODH/MAPK PathwayLei Chang, Xinzhou Deng, Shan Jiang, et al.
Cancer Biology & Therapy|April 24, 2014
A phase II randomized trial evaluating gefitinib intercalated with pemetrexed/platinum chemotherapy or pemetrexed/platinum chemotherapy alone in unselected patients with advanced non-squamous non-small cell lung cancerHui Yu, Jian Zhang, Xianghua Wu, et al.
Investigational New Drugs|November 3, 2021
Rh-endostatin combined with chemotherapy in patients with advanced or recurrent mucosal melanoma: retrospective analysis of real-world dataXiaowei Zhang, Feng Jin, Shiyu Jiang, et al.
Frontiers in Oncology|December 16, 2021
GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung AdenocarcinomaJiahui Han, Xinzhou Deng, Renhuang Sun, et al.
Cancer Research and Treatment|March 14, 2023
Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center StudyXin Liu, Chengcheng Gong, Jieyun Zhang, et al.
Cell Communication and Signaling : CCS|February 7, 2024
1-Pyrroline-5-carboxylate inhibit T cell glycolysis in prostate cancer microenvironment by SHP1/PKM2/LDHB axisLei Chang, Guohao Li, Shan Jiang, et al.
Cell Death & Disease|July 3, 2020
Chondroitin polymerizing factor (CHPF) promotes development of malignant melanoma through regulation of CDK1Wei Sun, Fang Zhao, Yu Xu, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|August 24, 2025
A highly sensitive ESIPT fluorescent probe for visualization of HK2-mediated lung cancer progression via imaging nitroreductaseMiao Chen, Kelong Wang, Han Zhang, et al.
Clinical and Translational Medicine|April 16, 2025
Fruquintinib as first-line or second-line treatment in unresectable or metastatic soft-tissue sarcoma: A prospective, single-arm phase II studyXiaowei Zhang, Ting Zhao, Biqiang Zheng, et al.
Nature Communications|May 8, 2026
Anti-PD-1 plus nab-paclitaxel and bevacizumab for second-line treatment of cancer of unknown primary (Fudan CUP-002): a phase II trialXiaowei Zhang, Ting Zhao, Midie Xu, et al.
Pageof 13